Ana Valeria Meléndez Mayorga
Works:
- Lectin-based tools for cancer immunotherapy targeting the glycosphingolipid Gb3
- A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
- A Shiga toxin B-subunit-based lectibody boosts T cell cytotoxicity towards Gb3-positive cancer cells
- Dimeric lectin chimeras as novel candidates for gb3-mediated transcytotic drug delivery through cellular barriers